Results Snapshot
Quarterly Analysis Highlights - YoY
Net Sales
YoY Growth in quarter ended Sep 2025 is 28.75% vs -3.10% in Sep 2024
Consolidate Net Profit
YoY Growth in quarter ended Sep 2025 is 1,528.57% vs -105.38% in Sep 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in quarter ended Sep 2025 is -49.71% vs -23.45% in Sep 2024
Interest
YoY Growth in quarter ended Sep 2025 is -13.04% vs 155.56% in Sep 2024
Operating Profit Margin (Excl OI)
YoY Growth in quarter ended Sep 2025 has improved from Sep 2024
Compare Quarterly Results Of PharmaResources (Shanghai) Co., Ltd With
Quarterly - Net Sales
QoQ Growth in quarter ended Sep 2025 is -11.82% vs 8.36% in Jun 2025
YoY Growth in quarter ended Sep 2025 is 28.75% vs -3.10% in Sep 2024
Quarterly - Consolidate Net Profit
QoQ Growth in quarter ended Sep 2025 is -21.88% vs 6.67% in Jun 2025
YoY Growth in quarter ended Sep 2025 is 1,528.57% vs -105.38% in Sep 2024
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Sep 2025 is -74.11% vs 3.38% in Jun 2025
YoY Growth in quarter ended Sep 2025 is -49.71% vs -23.45% in Sep 2024
Quarterly - Interest
QoQ Growth in quarter ended Sep 2025 is -4.76% vs -4.55% in Jun 2025
YoY Growth in quarter ended Sep 2025 is -13.04% vs 155.56% in Sep 2024
Quarterly - Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Sep 2025 has fallen from Jun 2025
YoY Growth in quarter ended Sep 2025 has improved from Sep 2024






